Although several factors are at play in influencing platelets during established RA, we believe that, especially in the initiating (symptom-free) phase of the disease, ACPA-mediated activation of platelets could have an important role in enhancing the basal activation status of platelets, as ACPA can be detected many years before disease onset. Here, PRTN3 is linked to rheumatoid arthritis.